Becton Dickinson & Co.
Income Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Revenue | $6.99B | $6.90B | $6.28B |
| BD Medical | — | — | — |
| BD Life Sciences | — | — | — |
| BD Interventional | — | — | — |
| Corporate and Other | — | — | — |
| Cost of Revenue | $3.31B | $3.36B | $3.03B |
| Gross Profit | $3.68B | $3.54B | $3.25B |
| Gross Margin | 52.6% | 51.3% | 51.7% |
| Operating Expenses | |||
| Research & Development | $404.6M | — | — |
| SG&A Expense | $1.68B | $1.67B | $1.58B |
| Operating Income | $1.59B | $1.49B | $1.18B |
| Operating Margin | 22.8% | 21.6% | 18.9% |
| Interest Expense | $40.4M | $36.3M | $46.4M |
| Pretax Income | $1.58B | $1.49B | $1.19B |
| Income Tax Expense | $411.2M | $411.9M | $343.9M |
| Net Income | $1.23B | $1.13B | $890.0M |
| Net Margin | 17.6% | 16.3% | 14.2% |
| EPS (Basic) | $5.12 | $4.61 | $3.63 |
| EPS (Diluted) | $4.99 | $4.46 | $3.49 |
| Shares Outstanding (Basic) | 240.5M | 244.3M | — |
| Shares Outstanding (Diluted) | 246.8M | 252.7M | — |
| Dividends Per Share | $1.32 | $1.14 | — |